HealthStream downgraded at Craig-Hallum on high valuation

What happened

Craig-Hallum downgraded HealthStream to hold from buy, saying the stock's run-up has made it overvalued. Shares are up about 39% year to date and about 50% over six months. The firm has a $40 price target, about 16% upside based on the Nov. 2 close.

Confirmed

Global impact / market context

The downgrade signals that the analyst thinks good business prospects are already reflected in the share price. For investors, that means strong demand for healthcare learning and scheduling tools may not translate into further stock gains without a new product or a meaningful acquisition.

Analyst inference

HealthStream is shifting customers to bundled suite solutions that combine several purchasing decisions into one, with lower price per piece but larger contracts and longer commitments. It also faces headwinds next year from moving to Amazon Web Services and winding down some higher margin applications, which means profit per sale may be pressured.

Analyst inference

What to watch

1. The analyst said the stock's ability to move materially higher from here, without a new product launched internally or a meaningful acquisition, will be challenging. Confirmed
2. Watch whether HealthStream launches a new product internally or makes a meaningful acquisition, the two paths the analyst cites as needed for further stock gains. Proposed
3. Track the move of HealthStream's software to Amazon Web Services for cloud service and the wind-down of some higher margin applications, which the analyst expects to create headwinds next year. Analyst inference

Evidence

• seekingalpha.com